Prevalence Study Of Hepatitis B (Australian Antigen) Among Patient In National Orthopediae Hospital Enugu
Click here to download our android mobile app to your phone for more materials and others
COMPLETE PROJECT MATERIAL COST 3000 NAIRA
Note: our case study can be change to suit your desire location . we are here for your success.
ORDER NOW
GTBANK
Account Name : Chi E-Concept Int’l
ACCOUNT NUMBER: 0115939447
First Bank:
Account Name: Chi E-Concept Int’l
Account Name: 3059320631
Note: We accept bank transfer, ATM cash transfer , Online payment using your ATM , Western union bank transfer. We will respond to you anytime of the day.
Or
Pay Online Using Your Atm Card. It Is Secured And Reliable.
form>
Call Help Desk On : 08074466939,08063386834.
After Payment Send Your Payment Details To
08074466939 Or 08063386834, The Project Title You Selected From Our Website, Amount Paid, Depositor Name, Ur Email Address,Payment Date. You Will Receive Your Material In Less Than 1 Hour Once We Confirm Your Payment.
WE HAVE SECURITY IN OUR BUSINESS.
MONEY BACK GUARANTEE
Click here to download our android mobile app to your phone for more materials and others
You May Also Need: Web Design Company in Nigeria.
You May Also Need: Bulk sms Company in Nigeria.
ABSTRACT
The prevalence of viral hepatitis B among patients in National Orthopedic Hospital Enugu was studied. The samples comprised that of men , woman and children 200 in numbers, all patient of orthopedic Hospital Enugu. Laboratory investigation done were this HBs tested which 110 patient out of the 200 patients tested positive, and liver function tests found abnormal in almost all the patients that tested positive to HBsAG routine test. The commonest clinical presentations were fever and jaundice seen in Jo patient out of the 110 patients. The infection was highest amongst young adult 21-30 years of age. This accounted for 17.5% of the positive patients population it was lowest amongst children 1-10 and old people 60-70 which made up 5% of the infected population. The study also gave the general view of the group of individual affected whether children or adult, and the wid expired of the repetitious B. Hepatitis B one of the major cause of human suffering in the world despite a though understanding of its transmission and prevention and control by use of vaccine was found to be prevalent in National Orthopedic Hospital Enugu among the patients.
TABLE OF CONTENT
Title page
CHAPTER ONE
Introduction
1.1: introduction to hepatitis b
1.2 Purpose of study
1.3 Significant of study
1.4 Statement of problem
1.5 Limitation of study
1.6 Hypothesis
CHAPTER TWO
Literature review
2.1 Structure of hepatitis b virus
2.2 The genome and its organization
2.3 Taxonomy of the hepatitis b virus
2.4 Reproduction (repcication) of hepatitis bb virus
2.5 Origin of the term “ Australian aborigine”.
2.6 Mode of transmission of hepatitis b
2.7 Hbv and cell damage (Cytopathic effects)
2.8 Hepatitis b virus and hepatocellular, carcin0ns
2.9 Hepatitis b virus infection: acute and chronic
2.10 Prevention and control
2.11 Site of injection for vaccination
2.12 People at risk of contacting the virus
CHAPTER THREE
3.1: materials used
3.2 Test for the presence of hepatitis b and
3.3 Principle for the above test
3.4 Serum bilirubin
3.5 Principle for the test above
CHAPTER FOUR
Result
CHAPTER FIVE
5.1 discussion and conclusion
5.2 Conclusion
5.3 Recommendation
References
LIST OF TABLE
Table 1: age distribution of the infected population 33
Table 2: Sex distribution of the infected population 33
Table 3: Area distributions of the infected population 33
Table 4: The six categories of patients showing the number of Infected persons 33
Table 5: Result of the test using the six categories of patients 34
CHAPTER ONE
INTRODUCTION
1.1 INTRODUCTION TO HEPATITIS B
Viral hepatitis is a disease as old as the history of Medicine. Hepatitis was described in the Babylonian Talmud in the fifty century BC, and was referred to by Hippocratic over 2000 years ago. Despite this ancient knowledge, it was not until 1963, that the first human Repetitious virus was isolated, Hepatitis B. This was followed quickly by the purification of Hepatitis A in 1973, and more recently by the isolation of viruses C, D, E and G. These viruses are known to infect the human liver (Anderson et al; 2001).
However, there are more than twenty other viruses, which infect the human liver. These are not considered “Repatitis viruses” as these other viruses tend to infect organs other than the liver more seriously’. These include common viruses such as Cytomegalovirus (CMV), Mumps, Rubella, Epstein-Barr virus (EBV) as well as rare ones such as Rassa fever and yellow fever viruses.
Any infection that results in inflammation of the liver is called Repatitis (Greek Repaticus, liver). Incidentally, not all “hepatitis” is caused by viruses. “HEPATITIS” means “inflammation of the liver”, and can be caused also by other types of infection (bacteria fungi etc); toxic drugs; poisons; alcoholism and so on (Drexott etal; 2005).
But of interest is one Repatitis virus – one of the most common infections diseases, causing an estimated 1.5millon deaths world wide each year – Hepatitis B. Hepatitis B is caused by the Repatitis B virus (HBV), a double – stranded circular DNA virus of complex structure. Hbv is class ivied as an orthoropadnavirus within the family hepadnaviridae. HBV was originally recognized as the age responsible or serum Repatitis the most common form of partially transmitted viral Repatitis and an import cause of acute and chronic infection of the liver. This why hepatitis b is some times called seum Repatitis.
The virus was formerly and anilines referred to as Australian antigen. The reason being that it was first isolated room the blood of an Australian aborogie and is associated with HBV. (procott et al 2005.
Hepatitis B remain one of the major cause of human suffering in the world despite a through understanding of its transmission and prevention. Serum form undivided infected with hepatitis B contains three district antigen particles: a spherical 22nm particle, a 42 nm spherical particle ( counting DNA and DNA polymer able) called the Dane particle, and tubular or filamentous particles that vary in length. The small spherical and tubular particles are the unassembled component of the Dane particle- the infective form of the virus. The unassembled particles. Contain hepatitis B surface antigen (HBsAg) whose presence in the blood is (a) an indicator of Repatitis B infection (b) the basis for the large scale screening of blood for the hepatitis B virus, and (c) the basis for the first vaccine for human use developed by recombinant DNA technology (Evans, 1997
The Hepatitis B virus is normally transmitted through blood transfusion, contaminated equipment, drug users unsterile needles, or any body secretion (saliva, soren, sweat, breast milk, urine) The virus also can pass from the blood of an infected mother through the placenta to infect the fetus. Each year an estimated 200, 000 people in Nigeria are infected with Australian Antigen (HBV) about 1000 person die yearly from hepatitis related cirrhosis and about 5000 die from HBV related liver cancer. (HBV is second only to tobacco as a known cause of rumen cancer). Worldwide, HBV infects over 200 million people (Schlesinger & Schlesinger, 2001). The clinccal signs of Repatitis B vary widely, most cases are symptomless. However, sometime fever, loss of appetite, abominal discomfort, nausea, fatigue, and other symptoms gradually appear following an incubation period of 1 to 3 months. The virus infects liver Hepatic cells and causes liver tissue degeneration and the release of liver associated enzymes (transaminases) into the blood team. This is followed by jaundice, the accumulation of bilirubin (a breakdown product of raemoglobin in the skin and other tissue with a resulting yellow appears. The distinctive yellow jaundice the Hepatitis B usually imparts to its victims skin has made it an rasity detectable disease through recorded history. Frequently, acute hepatitis B in anicteric and symptomatic, although acute liver failure may develop.
The virus persists in about 10 percent of infected immouno compent adults, and in as many 90 percent of infants infect peninatally depending on the ethnic group of the mother. About 350 million people worldwide are persistent carries of hepatitis B. actually one in twenty infection results in chronic hepatitis, defined as persistent hepatitis virus six mouths after the onset of the acute illness. Chronic HBV infection can be entirely begin with normal liver blood tests (“Chronic Carrier State”) or may be an aggressive inflammatory process (“Chronic active hepatitis”), which can lead to severe scarring (“Cirrhosis).
Approximately 25 percent of all patients with chronic hepatitis will progress to cirrhosis and about 20 percent of those with cirrhosis will develop hepatocellular carcinoma. That is to say, the risk of liver cancer (hepatoma) is high in cirrhosis caused by HBV.
Hepatocellular carcinoma is one of the most common cancers worldwide (Seeger & manor; 2000)
During the first phase of chronicity, virus replication continues in the liver and replicative intermediates of the viral genome may be detected in DNA extracted from liver hiopsies. Makers of virus replication in serum include HBVDNA (this indicated virus presence and activity), DNA polymerize (determines the presence of HBVDNA in liver cell, and a soluble antigen, hepatition.be antigen (HbeAG), which is secreted by productively infected hepatocytes. In those infected at a very going age this phase may persist for life but, more usually, virus levels decline over time. Eventually, in most individuals, there is immune clearance of infected hepatocytes associated with seroconverision low replication, the viral senome may integrate into the chromosomal DNA of some hepatocytes and these cells may persist and expand closely. Rarely , seroconversion to anti-HBs follows clearance of virus replication but, more frequently, HBSAg persists during a second phase of chronicity as a result of the expression of integrated viral DNA.
VIRAL REPLICATION
With respect to replication of the HBV, the fundamental process of viral infection is the expression of the viral replication cycle in a rost cell. The steps